International Patent: FIBROBLAST ACTIVATION PROTEIN-TARGETING CAR T-CELL, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

GENEVA, July 9 -- GUANGZHOU ANJIE BIOMEDICAL TECHNOLOGY CO;LTD filed a patent application (CN2025/105897) for “FIBROBLAST ACTIVATION PROTEIN-TARGETING CAR T-CELL, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF”. With publication no. WO/2026/144067, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 15/867

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....